ALECSO to Partner With SNC to Launch First Conference on International Organizations of Education, Science and Culture
The Arab League Educational, Cultural and Scientific Organization (ALECSO), in cooperation with the Saudi National Commission for Education, Culture and Science (SNC), is set to host the inaugural edition of a major international conference on culture, science and education in the 21st century.
The conference, ‘Future of Education, Science, and Culture International Organizations Forum’ (FESCIOF) will take place over two days from March 8-9, 2023, at the King Abdullah Petroleum Studies and Research Center (KAPSARC) in the Saudi capital Riyadh, with the participation of a number of major international organizations in the fields of education, culture and science.
FESCIOF will host an unprecedented gathering of international organizations and global entities across a variety of sectors with the goal of enabling collaboration and facilitating cross-sectoral dialogue.
Expected attendees include top international and multilateral organizations; regional institutions; national and regional policymakers; representatives of international and regional development banks; global and national academic institutions; international and regional organizations and institutions; major global and regional corporations, charitable foundations; NGOs; and a variety of subject-matter experts.
The conference aims to create a platform to strengthen relations across international and multilateral organizations, and to provide a space for the effective exchange of ideas and solutions for global challenges. FESCIOF will also develop joint flagship initiatives at the sectorial level.
Commenting on the announcement, Prince Badr bin Abdullah bin Farhan Al-Saud, the Saudi Minister of Culture and Chairman of the Saudi National Commission for Education, Culture and Science said: “I am proud to announce our partnership with ALECSO to deliver the first-ever Future of Education, Science, and Culture International Organizations Forum. FESCIOF represents a genuine milestone to align objectives across sectors and bring about tangible positive change.
“We are looking forward to hosting FESCIOF in Riyadh to explore and enhance opportunities for international organizations in the sectors of education, science, and culture and their expanded ecosystems.
“True impact requires collaboration across sectors and countries. This platform will allow participating organizations to draw from each other’s strengths.”
The Director General of ALECSO, H.E. Prof. Dr. Mohamed Ould Amar, said: “We at ALECSO are proud to be working with our key partner, SNC, to launch this global reaching and highly impactful initiative.
"We hope FESCIOF can be a catalyst for new synergies that cut through silos. We believe the conference will result in tangible impact through the creation of joint initiatives which will help to establish partnerships and new understandings between sectors.”
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230201005477/en/
Contact information
Haitham Haddadin
HHaddadin@apcoworldwide.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cross-Border Private Credit Set to Surge, But Operational Complexity Threatens Momentum, CSC Finds4.12.2025 15:30:00 EET | Press release
Cross-border private credit transactions are poised for strong growth, yet operational complexity is emerging as a critical hurdle. According to CSC, the leading provider of business administration and compliance solutions, an overwhelming 92% of limited partners (LPs) express concern over the complexity of these deals. Published in CSC’s latest report, Private Credit 2025: Global Strategies for a $1.5 Trillion Market, the findings highlight a growing disconnect between investors and fund managers as private credit continues its rapid international expansion. 1 While both LPs and general partners (GPs) remain optimistic about the growth of cross-border private credit, they diverge sharply when it comes to operational readiness. Nearly eight in 10 GPs (79%) anticipate growth in the sector over the next three years, with more than half (51%) expecting a significant acceleration. LPs, however, are increasingly cautious—40% reported turning down multiple fund or investment opportunities la
Pace selected by Prudential Financial to help automate its insurance operations with agentic AI4.12.2025 15:15:00 EET | Press release
Pace, the agentic workforce for insurance, was chosen by Prudential’s Individual Life Insurance (ILI) business to help simplify and improve its service delivery. Pace’s AI-powered agents are now streamlining policy servicing and supporting quality assurance efforts within Prudential’s ILI business. The first set of automated systems is now live taking on thousands of hours of work. “Our work with Prudential is an example of how AI can be used as a strategic advantage,” said Pace CEO Jamie Cuffe. “We’re thrilled to support their exceptional team with AI agents in production today that deliver best-in-class accuracy and speed at significant scale.” This multi-year agreement between Pace and Prudential’s ILI business began as a pilot and quickly moved to full production after demonstrating clear improvements in speed and operational efficiency. “We’ve taken a step forward on our journey to modernize the customer acquisition process,” said Sara Atkinson, vice president of customer acquisit
Redefining Acromegaly Care: First Patient Randomized in Debiopharm’s Phase III OXTEND-03™ Trial of 3-Month Debio 4126 Treatment4.12.2025 15:00:00 EET | Press release
Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company committed to establishing tomorrow’s standards of care in oncology and rare diseases, today announced that the first patient has been randomized in the OXTEND-03™ clinical trial. This pivotal Phase III trial is designed to evaluate the efficacy and safety of Debio 4126, a novel long-acting octreotide formulation and the first potential 3-month somatostatin analogue (SSA), in adults with acromegaly who are currently maintained on somatostatin analogs. OXTEND-03™ is a global trial spanning approximately 75 sites across 21 countries, aiming to enroll around 120 patients. The primary goal of the trial is to confirm Debio 4126’s ability to maintain biochemical control of the disease while significantly reducing the patient’s annual treatment burden from 12 injections to just 4. This shift is expected to enhance patient convenience, improve long-term adherence, and potentially decrease healthcare resour
Visa Launches Global Art Collection to Elevate Creators and Celebrate the FIFA World Cup 26™4.12.2025 15:00:00 EET | Press release
Visa today unveiled the first five pieces in its first-ever global art collection celebrating the cultural energy of the FIFA World Cup 26™. Featuring more than twenty artists from six continents, the collection reflects Visa’s belief that creativity drives commerce—and that today’s creators are the entrepreneurs shaping communities and culture around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204080105/en/ Darien Birks (Global) Visa debuted the first five pieces in the collection at an exclusive Miami showcase, “The Art of the Draw”, hosted by multidisciplinary creator KidSuper. The showcase featured the works of artists Darien Birks, Nathan Walker, Cesar Canseco, Ivan Roque, and Rafael Mayani that celebrate the culture and traditions of each host country and host city Miami. The full collection will be unveiled globally ahead of next summer’s tournament. Commerce Meets Culture Visa will collaborate with J
Parse Biosciences Launches Evercode Whole Blood Fixation4.12.2025 15:00:00 EET | Press release
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of Evercode™ Whole Blood Fixation, a new kit that enables immediate fixation of whole blood directly at the point of collection. The technology eliminates the need for on-site PBMC isolation, specialized equipment, or trained personnel, allowing translational hematology and pharmaceutical research teams to seamlessly collect blood samples in real-world clinical settings for downstream single cell analysis. Traditional single cell RNA profiling workflows done in a translational setting require a compromise between processing fresh samples, which degrade rapidly and demand skilled handling, and using fixation approaches that capture only a partial transcriptome and cannot provide paired TCR sequences. Fresh PBMC isolation also requires complex workflows and specialized reagents. Evercode Whole Blood Fixation overcomes these limitations, preserving the comprehensiv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom